PharmaBoardroom

Interview with Judith Greciet, President, Eisai France

Aricept has been a very effective blockbuster for the group as a whole and the loss of exclusivity affects not only France but entire company. How is…

Interview with Jean De Szolnok, President, Boehringer Ingelheim…

There is a lot of change occurring in the French pharmaceutical industry at the moment and this is no different for Boehringer Ingelheim. Just last…

Interview with Christian Lajoux, President of Sanofi-Aventis…

As president of LEEM, what will be your legacy and what legacy would you like to instill in the organization? A legacy of re-industrialization in the…

Interview with Giovanni Recordati, Chairman & CEO, Recordati

Recordati was created in 1926, and the combined work of three generations turned the small laboratory not only into a local success story but also a…

Interview with Eric Zwisler, CEO of Zuellig Pharma Asia Pacific,…

You started the Chinese operations and have been working in the country for many years but recently moved up to running all operations in Asia…

Interview with Leonhard Terp, General Manager Specialty Pharma…

The acquisition of Jerini has to be one of the biggest milestones for Shire Deutschland in its recent history. How have the synergies developed…

Interview with Harald Stock, CEO, Grünenthal

You arrived at Grünenthal fairly recently, in January of this year. What was it about the company that attracted you to the position? That goes back…

Interview with Sophie Kornowski-Bonnet, President, France, Roche…

Roche has a long history in France and currently enjoys a higher position than its worldwide ranking. Can you elaborate on the importance of this…

Interview with Jean-Luc Bélingard, CEO, Ipsen France

As the G5 brings together five very different companies - Ipsen, LFB, Pierre Fabre, Sanofi-Aventis, Servier - could you explain the origin behind the…